• Explore /
  • Poster
  • / Germline alterations other than <em>BRCA</em> in triple negative breast cancer (TNBC) patients who underwent neoadjuvant therapy (NAT) on a prospective clinical trial.

Germline alterations other than BRCA in triple negative breast cancer (TNBC) patients who underwent neoadjuvant therapy (NAT) on a prospective clinical trial.

Abstract Poster

Authors

Banu Arun

Banu Arun

The University of Texas MD Anderson Cancer Center, Houston, TX

Banu Arun , Li Zhao , Roland L. Bassett Jr., Alastair Mark Thompson , Jason B White , Rachel M. Layman , Angelica Gutierrez Barrera , Vicente Valero , Naoto T. Ueno , Jennifer Keating Litton , Jianhua Zhang , Elizabeth Ravenberg , Rosalind P Candelaria , Gaiane M Rauch , Debu Tripathy , Stacy L. Moulder

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Cancer Prevention, Risk Reduction, and Genetics

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Citation

J Clin Oncol 38: 2020 (suppl; abstr 1546)

DOI

10.1200/JCO.2020.38.15_suppl.1546

Abstract #

1546

Poster Bd #

38

Abstract Disclosures

Similar Posters

First Author: Bora Lim

First Author: Reva K Basho

First Author: Clinton Yam

First Author: Nour Abuhadra